Skip to main content

Pfizer TLZ 0.25 Pill - white capsule-shape

Generic Name: talazoparib

Pill with imprint Pfizer TLZ 0.25 is White, Capsule-shape and has been identified as Talzenna 0.25 mg. It is supplied by Pfizer Inc.

Talzenna is used in the treatment of Breast Cancer; Prostate Cancer and belongs to the drug class PARP inhibitors. Talzenna 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer TLZ 0.25

Talzenna 0.25 mg Pfizer TLZ 0.25

Talzenna

Generic Name
talazoparib
Imprint
Pfizer TLZ 0.25
Strength
0.25 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
PARP inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer Inc.
National Drug Code (NDC)
00069-0296

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.